Medeva Pharma Limited
Records under this name other than patents Medeva Pharma Limited holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,479,283 | Acellular pertussis vaccine comprising a combination of the 69 kDa and the filamentous haemagglutinin antigens of Bordetella pertussis Formerly held Term ended Term ended Jan 20, 2026 · From the USPTO record | Term ended | Term ended Jan 20, 2026 | From the USPTO record |
| US 6,197,548 | Transformed Pichia expressing the pertactin antigen Term ended Term ended Mar 6, 2018 · From the USPTO record | Term ended | Term ended Mar 6, 2018 | From the USPTO record |
| US 6,127,151 | Antigenic preparations and the isolation of such preparations Formerly held Term ended Term ended Oct 3, 2017 · From the USPTO record | Term ended | Term ended Oct 3, 2017 | From the USPTO record |
| US 6,060,067 | Process for the preparation of tetanus toxoid vaccine Formerly held Term ended Term ended May 9, 2017 · From the USPTO record | Term ended | Term ended May 9, 2017 | From the USPTO record |
| US 6,048,700 | Antigenic preparations and the isolation of such preparations Formerly held Term ended Term ended Apr 11, 2017 · From the USPTO record | Term ended | Term ended Apr 11, 2017 | From the USPTO record |
| US 6,210,685 | Antigenic preparations and isolation of such preparations Formerly held Lapsed on the fee record Ended Apr 3, 2013 · From the USPTO record | Lapsed on the fee record | Ended Apr 3, 2013 | From the USPTO record |
| US 5,237,052 | Antigenic preparations and isolation of such preparations Term ended Term ended no later than Aug 17, 2013 · Low confidence | Term ended | Term ended no later than Aug 17, 2013 | Low confidence |
| US 5,438,120 | Antigenic preparation and isolation of such preparations Term ended Term ended no later than Aug 1, 2015 · Low confidence | Term ended | Term ended no later than Aug 1, 2015 | Low confidence |
| US 5,506,129 | Virus production Formerly held Term ended Term ended no later than Apr 9, 2016 · Low confidence | Term ended | Term ended no later than Apr 9, 2016 | Low confidence |
| US 5,648,080 | Antigenic preparations and isolation of such preparations Term ended Term ended no later than Jul 15, 2017 · Low confidence | Term ended | Term ended no later than Jul 15, 2017 | Low confidence |